Sign in

Filings

Finds words inside filing documents. Searching LIGAND PHARMACEUTICALS INC's filings · 50 documents indexed.

12 documents · 21 matches

  1. LGND LIGAND PHARMACEUTICALS INC 8-K/A 2026-09-02

    share repurchases after December 31, 2022. The tax applies if the aggregate fair market value of repurchased stock during the taxable
    2 matches in this document

  2. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-08-06

    count following the Company’s share repurchase in connection with the convertible debt financing. Ligand continues to expect the following:
    1 match in this document

  3. LGND LIGAND PHARMACEUTICALS INC 10-Q 2026-10-30

    Item 1. Condensed Consolidated Financial Statements

    Share repurchase in connection with the 2031 Notes (Note 9) (229) — — — (60,000) (60,000)
    3 matches in this document

  4. LGND LIGAND PHARMACEUTICALS INC 10-Q 2026-08-07

    Item 1. Condensed Consolidated Financial Statements

    Share repurchase in connection with the 2031 Notes (Note 8) (229) — — — (60,000) (60,000)
    2 matches in this document

  5. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-06-25

    spreads and to fund concurrent share repurchase intended to offset potential dilution to Ligand’s common stock upon conversion of the notes
    2 matches in this document

  6. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-06-25

    spreads and to fund concurrent share repurchase intended to offset potential dilution to Ligand’s common stock upon conversion of the notes
    1 match in this document

  7. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-06-22

    spreads and to fund concurrent share repurchase intended to offset potential dilution to Ligand’s common stock upon conversion of the notes
    2 matches in this document

  8. LGND LIGAND PHARMACEUTICALS INC 10-Q 2026-05-08

    Item 1 · Note 8. Stockholders’ Equity

    Share Repurchases
    1 match in this document

  9. LGND LIGAND PHARMACEUTICALS INC 10-K 2026-02-27

    Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities

    share repurchases. Any future determination to pay dividends on common stock will be at the discretion of our Board of Directors
    3 matches in this document

  10. LGND LIGAND PHARMACEUTICALS INC 10-Q 2025-11-07

    Item 1. Condensed Consolidated Financial Statements

    Share repurchase in connection to the 2030 Notes (Note 7) (102) — (15,000) — — (15,000)
    2 matches in this document

  11. LGND LIGAND PHARMACEUTICALS INC 10-Q 2025-08-08

    Item 1 · Note 9. Stockholders’ Equity

    Share Repurchases
    1 match in this document

  12. LGND LIGAND PHARMACEUTICALS INC 10-Q 2025-05-09

    Item 1 · Note 9. Stockholders’ Equity

    Share Repurchases
    1 match in this document

Page 1 of 1 · 12 documents